Tower Research Capital (TRC)’s Edgewise Therapeutics EWTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $172K | Buy |
|
|||||
|
2025
Q4 | $40K | Sell |
|
|||||
|
2025
Q3 | $26.6K | Sell |
|
|||||
|
2025
Q2 | $120K | Buy |
|
|||||
|
2025
Q1 | $175K | Buy |
|
|||||
|
2024
Q4 | $98.1K | Buy |
|
|||||
|
2024
Q3 | $8.19K | Sell |
|
|||||
|
2024
Q2 | $101K | Buy |
|
|||||
|
2024
Q1 | $8.57K | Sell |
|
|||||
|
2023
Q4 | $200K | Buy |
|
|||||
|
2023
Q3 | $34.7K | Buy |
|
|||||
|
2023
Q2 | $9.48K | Sell |
|
|||||
|
2023
Q1 | $109K | Buy |
|
|||||
|
2022
Q4 | $59K | Buy |
|
|||||
|
2022
Q3 | $37K | Buy |
|
|||||
|
2022
Q2 | $10K | Sell |
|
|||||
|
2022
Q1 | $21K | Buy |
|
|||||
|
2021
Q4 | $20K | Buy |
|
|||||
|
2021
Q3 | $8K | Buy |
|
|||||
|
2021
Q2 | $6K | Buy |
|